Guided ImageryNCT07202650
THE EFFECT OF GUİDED IMAGERY ON PREMENSTRUAL SYNDROME
A study testing guided imagery in people with Guided Imagery and Premenstrual Syndrome, run by Baskent University at 1 site in Turkey (Türkiye).
Trial summary
EFFECT OF GUIDED IMAGERY ON PREMENSTRUAL SYNDROME IN UNIVERSITY STUDENTS Premenstrual Syndrome (PMS) is a condition characterized by physical, behavioral, and emotional symptoms that appear at the end of the luteal phase, 7-10 days before menstruation, and resolve with the onset of menstruation. Read more about this study
- Who is it for?
- Any age, women onlyHealthy volunteers can take part
- Conditions the study is for
- Guided Imagery, Premenstrual Syndrome, Nursing
- What is being tested?
- guided imagery
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 61 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 May 2026to 19 Oct 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- Women only
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Regular menstrual cycles (21-35 days over the last three cycles)
- Age 18 years or older
- No medical treatment for PMS
- Ability to communicate effectively in Turkish
- No psychiatric diagnosis or gynecological disorder (e.g., abnormal uterine bleeding, myoma, ovarian cysts)
- A score >89 on the Premenstrual Syndrome Scale (PMSS)
- No prior participation in guided imagery training
Who cannot join
- Failure to perform guided imagery at the correct time or in the prescribed manner
- Irregular menstruation during the last three months
- Use of contraceptives
- Use of analgesics during menstruation while participating in the study
Trial locations and contacts
1 site in 1 country.
About this study
Official title: EFFECT OF GUİDED IMAGERY ON PREMENSİVE SYNDROME İN UNİVERSİTY STUDENTS
EFFECT OF GUIDED IMAGERY ON PREMENSTRUAL SYNDROME IN UNIVERSITY STUDENTS
Premenstrual Syndrome (PMS) is a condition characterized by physical, behavioral, and emotional symptoms that appear at the end of the luteal phase, 7-10 days before menstruation, and resolve with the onset of menstruation. Symptoms include irritability, loss of control, anxiety, depression, sleep disturbances, decreased concentration, unexplained crying, fatigue, weakness, changes in appetite, edema, headaches, joint and muscle pain, breast tenderness, altered sexual activity, and social withdrawal. In young women, PMS can negatively affect self-confidence, social relationships, quality of life, and academic performance.
Read more
PMS treatment aims to relieve both physical and psychological symptoms and may include dietary supplements and complementary-alternative therapies. Approaches such as reflexology, pilates, acupressure, music, exercise, and guided imagery have shown promising results in reducing premenstrual symptoms. Mind-body-based approaches in complementary therapies are known to support psychological well-being. Guided imagery, a form of mind-body communication, involves the flow of thoughts and the way the mind encodes, stores, and expresses sensory information. It is based on the understanding that the mind and body are interconnected and that mental processes can influence physical responses. Guided imagery has been shown to reduce stress, improve mood, enhance sleep quality, strengthen the immune system, reduce fatigue, and minimize nausea and vomiting.
Although effective, research on the use of guided imagery to reduce PMS symptoms in university students is limited. This study aims to investigate the effect of guided imagery on premenstrual syndrome in this population.
Read the detailed description
Premenstrual Syndrome (PMS) is a condition characterized by physical, behavioral, and emotional symptoms that typically occur at the end of the luteal phase of a woman's menstrual cycle, 7-10 days before menstruation, and resolve at the onset of menstruation or shortly afterward. When diagnosing PMS, women are advised to keep a symptom diary for at least two menstrual cycles. The diary should document symptoms during the luteal phase and the symptom-free period until ovulation. Underlying physical or psychological conditions that could exacerbate symptoms should also be considered.
PMS can be diagnosed when symptoms occur for at least three consecutive menstrual cycles, beginning within five days before menstruation, ending within four days after menstruation starts, and interfering with normal daily activities. Evaluations should also consider medical, psychological, sociocultural, and lifestyle factors.
Symptoms of PMS include irritability, feelings of loss of control, anxiety, depression, insomnia or hypersomnia, difficulty concentrating, crying for no reason, fatigue, increased appetite, edema, weight gain, dizziness, headaches, joint and muscle pain, breast tenderness, changes in sexual activity, and avoidance of social interactions, among over 200 psychological, physical, and behavioral symptoms. Up to 90% of women of reproductive age report experiencing one or more of these symptoms in the days before menstruation, which can affect behavior, well-being, and social or work environments.
Although the exact cause of PMS is not fully understood, it is believed that endocrine factors-such as carbohydrate intolerance, fluid retention, progesterone deficiency, estrogen imbalance, endorphin deficiency, adrenal or thyroid dysfunction, hyperprolactinemia, and hypoglycemia-along with psychological factors like genetics and stress, contribute to its development.
Traditionally considered a concern for women of reproductive age, PMS is increasingly recognized as a common mental health issue, significantly impairing daily functioning. The COVID-19 pandemic has also been associated with an increase in some PMS symptoms. The wide range of PMS symptoms makes it challenging to determine its true prevalence, which varies widely across studies. Women often use both pharmacological and non-pharmacological strategies to manage physical and psychological symptoms during the premenstrual period. PMS can negatively affect self-confidence, social relationships, quality of life, and academic performance, making effective treatment increasingly important.
Treatment focuses on alleviating both physical and psychiatric symptoms, and may include dietary supplements and complementary-alternative therapies. Complementary approaches such as reflexology, pilates, acupressure, music, exercise, and guided imagery have shown promising results in reducing premenstrual symptoms. Mind-body approaches in complementary therapies are known to have psychological benefits. Among these, relaxation techniques are the most commonly used, aiming to neutralize stress-related physical changes, including muscle tension, high blood pressure, and hormonal fluctuations, while calming the mind.
Guided imagery is a mind-body communication technique that involves the flow of thoughts and how the brain encodes, stores, and recalls sensory information. It is based on the connection between mind and body, recognizing that the mind can influence physiological responses. Stress and anxiety directly affect the brain and immune system. Guided imagery can be practiced with an instructor or through pre-recorded audio or video, and individuals can also practice self-directed imagery, creating their own scenarios. It can be applied in groups or individually. This technique has been shown to reduce stress, improve mood, strengthen the immune system, reduce fatigue, enhance sleep quality, and minimize nausea and vomiting.
Studies among university students have shown that guided imagery effectively alleviates premenstrual symptoms. Additionally, hypnotherapy and virtual reality-based relaxation interventions have been found to reduce PMS symptoms. However, research on using guided imagery specifically for reducing premenstrual symptoms in university students is still limited.
- Conditions
- Guided Imagery, Premenstrual Syndrome, Nursing
- Being tested
- guided imagery
- Keywords
- premenstrual syndrome, guided imagery, university students, quality of life
- Medical subject headings
- Premenstrual Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
guided imageryBehavioural
Guided imagery is a form of mind-body communication, defined as a flow of thoughts involving what we smell, taste, see, hear, and touch, or as the way the mind encodes, stores, and retrieves information. Guided imagery is based on the understanding that the mind and body are interconnected and that the mind can influence bodily functions. Stress and anxiety directly affect the brain and the immune system.
| Study group | Role | What they receive |
|---|---|---|
| intervention group | Active comparator | At baseline, students in both the intervention and control groups will complete the Introductory Characteristics Data Collection Form, the Premenstrual Syndrome Scale, and the WHO Quality of Life Scale. Students in the intervention group with high PMS scores will be instructed to practice guided imagery for 15 minutes daily during two consecutive menstrual cycles-specifically, during the seven days prior to menstruation when symptoms begin and the first four days of menstruation. The control group will receive no intervention.
Throughout the study, intervention group participants will complete the Menstrual Cycle Follow-up Form and the Guided Imagery Follow-up Form, while control group participants will complete only the Menstrual Cycle Follow-up Form. After two cycles, both groups will again complete the Premenstrual Syndrome Scale and the WHO Quality of Life Scale. Receives: Behavioral: guided imagery |
| control group | No intervention | At baseline, students in both the intervention and control groups will complete the Introductory Characteristics Data Collection Form, the Premenstrual Syndrome Scale, and the WHO Quality of Life Scale. No intervention will be applied to the control group; however, they will be asked to complete the Menstrual Cycle Follow-up Form throughout the study. After two menstrual cycles, both groups will again complete the Premenstrual Syndrome Scale and the WHO Quality of Life Scale. |
What is being measured
The primary outcome is the main question the study is designed to answer.
premenstrual syndrome
The Premenstrual Syndrome Scale, developed by Gençdoğan (2006), is a five-point Likert-type instrument consisting of 44 items designed to assess the severity of premenstrual symptoms, based on DSM-III and DSM-IV-R criteria. In scoring, responses are rated as follows: "None" = 1 point, "Very little" = 2 points, "Sometimes" = 3 points, "Often" = 4 points, and "Always" = 5 points.
Measured: two months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Oct 2025
- Study start15 May 2026
- Primary completion19 Oct 2026
- Study completion19 Oct 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Guided ImageryStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- randomized controlled trial
- Masking
- None (open label)
- Enrolment
- 61 participants (actual)
Sponsor and investigators
- Lead sponsor
- Baskent University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07202650
- Sponsor's protocol ID
- KA25/200
- Status last verified
- Oct 2026
- First submitted
- 24 Sep 2025
- Last updated
- 22 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- EFFECT OF GUİDED IMAGERY ON PREMENSİVE SYNDROME İN UNİVERSİTY STUDENTS
- ClinicalTrials.gov ID
- NCT07202650
- Acronym / sponsor ID
- KA25/200
- Conditions
- Guided Imagery, Premenstrual Syndrome, Nursing
- Keywords
- premenstrual syndrome, guided imagery, university students, quality of life
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 61 participants (actual)
- Lead sponsor
- Baskent UniversityUniversity, hospital or other
- Study start
- 15 May 2026 (actual)
- Primary completion
- 19 Oct 2026 (actual)
- Study completion
- 19 Oct 2026 (actual)
- First posted
- 2 Oct 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
EFFECT OF GUIDED IMAGERY ON PREMENSTRUAL SYNDROME IN UNIVERSITY STUDENTS
Premenstrual Syndrome (PMS) is a condition characterized by physical, behavioral, and emotional symptoms that appear at the end of the luteal phase, 7-10 days before menstruation, and resolve with the onset of menstruation. Symptoms include irritability, loss of control, anxiety, depression, sleep disturbances, decreased concentration, unexplained crying, fatigue, weakness, changes in appetite, edema, headaches, joint and muscle pain, breast tenderness, altered sexual activity, and social withdrawal. In young women, PMS can negatively affect self-confidence, social relationships, quality of life, and academic performance.
PMS treatment aims to relieve both physical and psychological symptoms and may include dietary supplements and complementary-alternative therapies. Approaches such as reflexology, pilates, acupressure, music, exercise, and guided imagery have shown promising results in reducing premenstrual symptoms. Mind-body-based approaches in complementary therapies are known to support psychological well-being. Guided imagery, a form of mind-body communication, involves the flow of thoughts and the way the mind encodes, stores, and expresses sensory information. It is based on the understanding that the mind and body are interconnected and that mental processes can influence physical responses. Guided imagery has been shown to reduce stress, improve mood, enhance sleep quality, strengthen the immune system, reduce fatigue, and minimize nausea and vomiting.
Although effective, research on the use of guided imagery to reduce PMS symptoms in university students is limited. This study aims to investigate the effect of guided imagery on premenstrual syndrome in this population.
Detailed description
Premenstrual Syndrome (PMS) is a condition characterized by physical, behavioral, and emotional symptoms that typically occur at the end of the luteal phase of a woman's menstrual cycle, 7-10 days before menstruation, and resolve at the onset of menstruation or shortly afterward. When diagnosing PMS, women are advised to keep a symptom diary for at least two menstrual cycles. The diary should document symptoms during the luteal phase and the symptom-free period until ovulation. Underlying physical or psychological conditions that could exacerbate symptoms should also be considered.
PMS can be diagnosed when symptoms occur for at least three consecutive menstrual cycles, beginning within five days before menstruation, ending within four days after menstruation starts, and interfering with normal daily activities. Evaluations should also consider medical, psychological, sociocultural, and lifestyle factors.
Symptoms of PMS include irritability, feelings of loss of control, anxiety, depression, insomnia or hypersomnia, difficulty concentrating, crying for no reason, fatigue, increased appetite, edema, weight gain, dizziness, headaches, joint and muscle pain, breast tenderness, changes in sexual activity, and avoidance of social interactions, among over 200 psychological, physical, and behavioral symptoms. Up to 90% of women of reproductive age report experiencing one or more of these symptoms in the days before menstruation, which can affect behavior, well-being, and social or work environments.
Although the exact cause of PMS is not fully understood, it is believed that endocrine factors-such as carbohydrate intolerance, fluid retention, progesterone deficiency, estrogen imbalance, endorphin deficiency, adrenal or thyroid dysfunction, hyperprolactinemia, and hypoglycemia-along with psychological factors like genetics and stress, contribute to its development.
Traditionally considered a concern for women of reproductive age, PMS is increasingly recognized as a common mental health issue, significantly impairing daily functioning. The COVID-19 pandemic has also been associated with an increase in some PMS symptoms. The wide range of PMS symptoms makes it challenging to determine its true prevalence, which varies widely across studies. Women often use both pharmacological and non-pharmacological strategies to manage physical and psychological symptoms during the premenstrual period. PMS can negatively affect self-confidence, social relationships, quality of life, and academic performance, making effective treatment increasingly important.
Treatment focuses on alleviating both physical and psychiatric symptoms, and may include dietary supplements and complementary-alternative therapies. Complementary approaches such as reflexology, pilates, acupressure, music, exercise, and guided imagery have shown promising results in reducing premenstrual symptoms. Mind-body approaches in complementary therapies are known to have psychological benefits. Among these, relaxation techniques are the most commonly used, aiming to neutralize stress-related physical changes, including muscle tension, high blood pressure, and hormonal fluctuations, while calming the mind.
Guided imagery is a mind-body communication technique that involves the flow of thoughts and how the brain encodes, stores, and recalls sensory information. It is based on the connection between mind and body, recognizing that the mind can influence physiological responses. Stress and anxiety directly affect the brain and immune system. Guided imagery can be practiced with an instructor or through pre-recorded audio or video, and individuals can also practice self-directed imagery, creating their own scenarios. It can be applied in groups or individually. This technique has been shown to reduce stress, improve mood, strengthen the immune system, reduce fatigue, enhance sleep quality, and minimize nausea and vomiting.
Studies among university students have shown that guided imagery effectively alleviates premenstrual symptoms. Additionally, hypnotherapy and virtual reality-based relaxation interventions have been found to reduce PMS symptoms. However, research on using guided imagery specifically for reducing premenstrual symptoms in university students is still limited.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- randomized controlled trial
| Arm | Type | Receives |
|---|---|---|
| intervention group | Active comparator | Behavioral: guided imageryAt baseline, students in both the intervention and control groups will complete the Introductory Characteristics Data Collection Form, the Premenstrual Syndrome Scale, and the WHO Quality of Life Scale. Students in the intervention group with high PMS scores will be instructed to practice guided imagery for 15 minutes daily during two consecutive menstrual cycles-specifically, during the seven days prior to menstruation when symptoms begin and the first four days of menstruation. The control group will receive no intervention. Throughout the study, intervention group participants will complete the Menstrual Cycle Follow-up Form and the Guided Imagery Follow-up Form, while control group participants will complete only the Menstrual Cycle Follow-up Form. After two cycles, both groups will again complete the Premenstrual Syndrome Scale and the WHO Quality of Life Scale. |
| control group | No intervention | –At baseline, students in both the intervention and control groups will complete the Introductory Characteristics Data Collection Form, the Premenstrual Syndrome Scale, and the WHO Quality of Life Scale. No intervention will be applied to the control group; however, they will be asked to complete the Menstrual Cycle Follow-up Form throughout the study. After two menstrual cycles, both groups will again complete the Premenstrual Syndrome Scale and the WHO Quality of Life Scale. |
Who may qualify
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (7 listed)
- Regular menstrual cycles (21-35 days over the last three cycles)
- Age 18 years or older
- No medical treatment for PMS
- Ability to communicate effectively in Turkish
- No psychiatric diagnosis or gynecological disorder (e.g., abnormal uterine bleeding, myoma, ovarian cysts)
Key exclusion criteria (4 listed)
- Failure to perform guided imagery at the correct time or in the prescribed manner
- Irregular menstruation during the last three months
- Use of contraceptives
- Use of analgesics during menstruation while participating in the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| guided imageryGuided imagery is a form of mind-body communication, defined as a flow of thoughts involving what we smell, taste, see, hear, and touch, or as the way the mind encodes, stores, and retrieves information. Guided imagery is based on the understanding that the mind and body are interconnected and that the mind can influence bodily functions. Stress and anxiety directly affect the brain and the immune system. | Behavioural | intervention group |
Primary outcome
premenstrual syndrome
Time frame: two months
The Premenstrual Syndrome Scale, developed by Gençdoğan (2006), is a five-point Likert-type instrument consisting of 44 items designed to assess the severity of premenstrual symptoms, based on DSM-III and DSM-IV-R criteria. In scoring, responses are rated as follows: "None" = 1 point, "Very little" = 2 points, "Sometimes" = 3 points, "Often" = 4 points, and "Always" = 5 points.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Guided Imagery
RecruitingObservational study
Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in Accordance With Its Intended Use
Suspected Grade III and IV Gliomas Requiring Surgical Intervention, Neurosurgical Procedure
Not yet recruiting
Feasibility Study of a Relaxation and Guided Imagery Intervention Research Protocol for Use in School Settings.
Feasibility Studies, Acceptability
Recruiting
Positive Affirmations and Preoperative Anxiety
Total Joint Replacement Surgery, Preoperative Anxiety
Not yet recruiting
Clinical Hypnosis Versus Guided Imagery for Dissociative Symptoms in Adults
Dissociative Symptoms
Recruiting
VISION Study: Visualization-Guided SMAS Treatment to Optimize Nonsurgical Lifting
Facial Skin Laxity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing guided imagery in people with Guided Imagery and Premenstrual Syndrome, run by Baskent University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
premenstrual syndrome (time frame: two months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Oct 2026.